Axonal injury‐dependent induction of the peripheral benzodiazepine receptor in small‐diameter adult rat primary sensory neurons
- 16 July 2004
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 20 (3) , 671-683
- https://doi.org/10.1111/j.1460-9568.2004.03530.x
Abstract
The peripheral benzodiazepine receptor (PBR), a benzodiazepine but not γ‐aminobutyric acid‐binding mitochondrial membrane protein, has roles in steroid production, energy metabolism, cell survival and growth. PBR expression in the nervous system has been reported in non‐neuronal glial and immune cells. We now show expression of both PBR mRNA and protein, and the appearance of binding of a synthetic ligand, [3H]PK11195, in dorsal root ganglion (DRG) neurons following injury to the sciatic nerve. In naïve animals, PBR mRNA, protein expression and ligand binding are undetectable in the DRG. Three days after sciatic nerve transection, however, PBR mRNA begins to be expressed in injured neurons, and 4 weeks after the injury, expression and ligand binding are present in 35% of L4 DRG neurons. PBR ligand binding also appears after injury in the superficial dorsal horn of the spinal cord. The PBR expression in the DRG is restricted to small and medium‐sized neurons and returns to naïve levels if the injured peripheral axons are allowed to regrow and reinnervate targets. No non‐neuronal PBR expression is detected, unlike its putative endogenous ligand the diazepam binding inhibitor (DBI), which is expressed only in non‐neuronal cells, including the satellite cells that surround DRG neurons. DBI expression does not change with sciatic nerve transection. PBR acting on small‐calibre neurons could play a role in the adaptive survival and growth responses of these cells to injury of their axons.Keywords
This publication has 64 references indexed in Scilit:
- Proteins of peripheral myelin are associated with glycosphingolipid/cholesterol‐enriched membranesJournal of Neuroscience Research, 2002
- The peripheral benzodiazepine receptor ligand PK 11195 inhibits arthritis in the MRL-lpr mouse modelRheumatology, 1999
- Peripheral Benzodiazepine Receptor Agonists Exhibit Potent Antiapoptotic ActivitiesBiochemical and Biophysical Research Communications, 1999
- Benzodiazepine Receptor Agonists Modulate Thymocyte Apoptosis Through Reduction of the Mitochondrial Transmembrane PotentialThe Japanese Journal of Pharmacology, 1999
- Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's diseaseNeuroscience Letters, 1998
- Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell lineGlia, 1996
- Molecular and functional properties of mitochondrial benzodiazepine receptorsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- The mitochondrial permeability transition pore may comprise VDAC moleculesFEBS Letters, 1993
- Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistryHistochemistry and Cell Biology, 1992
- Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamideLife Sciences, 1983